These actions will improve the availability of tests, including for schools and underserved populations; increase domestic manufacturing of tests and testing supplies; and better prepare the nation for the threat of variants by rapidly increasing virus genome sequencing.
Read More
WHO’s yearly essential diagnostics list offers recommended in vitro diagnostics that should be available at point-of-care and in laboratories in all countries to increase timely and life-saving diagnoses.
Read More
HHS plans to provide weekly shipments of SARS-CoV-2 sample collection supplies to states and territories through at least March 2021.
Read More
Beckman Coulter’s Access SARS-CoV-2 Antigen assay is offered to healthcare providers at $4, making reliable and frequent mass testing affordable.
Read More
New research has shown that implementing point-of-care testing in hospitals to diagnose influenza can lead to better treatment and faster recovery for patients.
Read More